Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122114) titled 'A single-arm, multicenter, prospective clinical study on the treatment of locally advanced nasopharyngeal carcinoma with Adebrelimab combined with induction chemotherapy' on April 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Hospital Of Nanping
Condition:
Nasopharyngeal carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: Experimental group:28;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=314267
Published by HT Digital Content Services with per...